This site is intended for healthcare professionals only
LoginRegister
New TB Vaccine Safe,Temperature Stable and provides prompt Immune ResponseNew TB Vaccine Safe,Temperature Stable and provides prompt Immune Response
GSK, Pfizer ready to launch RSV vaccines for older adults in USGSK, Pfizer ready to launch RSV vaccines for older adults in US
Moderna COVID-19 vaccine linked to more delayed cutaneous reactionsModerna COVID-19 vaccine linked to more delayed cutaneous reactions
USFDA approves intramuscular administration for Merck’s MMRV Family of Vaccines: M-M-RII, VARIVAX, ProQuadUSFDA approves intramuscular administration for Merck’s MMRV Family of Vaccines: M-M-RII, VARIVAX,...
SEC Approves Serums Salk Polio Vaccine for Commercial Use, Recommends Phase I Trial for 21-valent Pneumococcal VaccineRevise Phase II/III CT protocol of Yellow Fever Vaccine Live: CDSCO Panel Tells Serum Institute of...
Health Ministry gets Porter Prize 2023 for COVID-19 managementHealth Ministry gets Porter Prize 2023 for COVID-19 management
Pfizers Abrocitinib Phase III Data Accepted by CDSCO Expert CommitteePfizer, BioNTech submit application to USFDA for emergency use nod of Omicron BA.4/BA.5-adapted...
Respiratory Syncytial virus vaccine effective in older adults, finds NEJM studyRespiratory Syncytial virus vaccine effective in older adults, finds NEJM study
USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas PharmaPfizer RSV vaccine for elderly linked to Guillain-Barre risk, says USFDA
Wockhardt plans to roll out two vaccines within year from UK facility as part of a tie-up with SIIWockhardt plans to roll out two vaccines within year from UK facility as part of a tie-up with SII
USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas PharmaPfizer, BioNTech seek USFDA nod for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine for ages 12...
USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas PharmaPfizer Respiratory Syncytial Virus Maternal Vaccine candidate gets USFDA priority review
X